PROSTATE • Mercurrey Hospital, Thane
Prostate Cancer in Thane — Mercurrey Hospital
Medically reviewed by Mr. Harshawardhan Godbole, MS, MCh, FRCS.Ed, DNB(Urol), FRCS(Urol)
Last medically reviewed: 21 May 2026
Last updated: 21 May 2026
Corporate health screenings along the Ghodbunder Road belt have been increasingly including PSA testing — and the result is a growing number of men from Hiranandani Estate, Manpada, and Brahmand receiving PSA results that require specialist interpretation. An elevated PSA on a health screening report can generate significant anxiety; in most cases, the elevation has a benign explanation, but a proportion will have prostate cancer that requires immediate specialist management. Mercurrey Hospital at Kapurbawdi junction — 10–15 minutes from most Ghodbunder Road residential communities — is the most practically accessible specialist prostate cancer assessment option for this corridor. Mr. Harshawardhan Godbole FRCS, Cancer Lead, interprets PSA findings in full clinical context and applies mpMRI as the pre-biopsy investigation standard.
Prostate cancer is the most common cancer in men in the UK and among the top three in India. PSA blood test, digital rectal examination (DRE), multiparametric MRI (mpMRI), and transperineal biopsy confirm diagnosis and Gleason/ISUP grade. Active surveillance is appropriate for low-risk disease. Radical prostatectomy (laparoscopic) and radical radiotherapy with hormone therapy treat high-risk localised disease. Hormone therapy (ADT) with chemotherapy or novel hormonal agents manages advanced and metastatic disease through specialist MDT. Mr. Godbole is Cancer Lead and MDT Lead at North Middlesex University Hospital NHS Trust.
### Health Screening PSA Results in the Ghodbunder Road Corporate Community
The proliferation of corporate health screening along the Ghodbunder Road belt has created a specific clinical scenario: executives and professionals in their 50s receiving PSA results in health screening reports with no clinical context — no DRE, no age-specific reference range, and no indication of what the next step should be. HRG Urology at Mercurrey Hospital is specifically equipped to address this: interpreting the PSA in the context of age, prostate size (estimated from DRE), PSA velocity where prior values are available, and PSA density — then determining whether mpMRI is indicated or whether reassurance is appropriate.
### Avoiding Over-Investigation and Under-Investigation in Prostate Cancer
The dual risk in prostate cancer management is treating cancers that would never have caused harm (over-treatment) and missing cancers that require treatment (under-investigation). At Mercurrey Hospital, Mr. Godbole's approach follows European Association of Urology (EAU) guidelines — which recommend mpMRI for men with elevated PSA before any biopsy, risk-stratified active surveillance for low-risk Gleason 6 cancers, and curative treatment for intermediate and high-risk disease. This evidence-based, guideline-adherent approach avoids both under-treating significant cancers and over-treating clinically insignificant ones.
### Travel and Parking Guide – Mercurrey Hospital, Kapurbawdi
High Street Mall Junction, Samata Nagar, Kapurbawdi, Majiwada 400607. From Hiranandani Estate: 10–12 minutes. From Manpada: 15 minutes. From Brahmand: 20 minutes. Auto-rickshaws know "Kapurbawdi High Street Mall." Street parking at the junction.
Why choose Mercurrey Hospital for prostate cancer?
- Hiranandani Estate and Ghodbunder Road professionals choose Mercurrey Hospital for prostate cancer assessment because the Kapurbawdi location is 10–20 minutes from their homes — making the multiple appointments of the diagnostic pathway (PSA interpretation, mpMRI, biopsy, staging discussion) logistically manageable.
- Mr. Godbole's guideline-adherent assessment at Mercurrey Hospital avoids both over-investigation (unnecessary biopsy for benign PSA elevation) and under-investigation (missing significant cancers) — particularly important for a patient community that researches medical decisions carefully.
- The Ghodbunder Road professional patient arrives informed and expects clinical evidence rather than reassurance: Mr. Godbole's cancer assessment meets this expectation with risk stratification, PIRADS scoring, Gleason grade explanation, and treatment option comparison.
Prostate Cancer cost at Mercurrey Hospital
Consultation fee: ₹1,000 at Mercurrey Hospital. Treatment costs vary — call +91 88280 71522 for a detailed estimate. [INTERNAL LINK → /fees/]
Risk factors for prostate Cancer:
- Older Age
- A family history of prostate cancer
- Obesity
- Genetic Changes
- Race/ethnicity (black males are at a higher risk of prostate cancer)
Symptoms of Prostate Cancer:
Prostatic symptoms may be similar for both benign and malignant causes and early urological attention and care would be advisable for some or all symptoms as below:
- Trouble urinating
- Blood in semen
- Decreased size and strength of urine stream
- Discomfort in pelvic area
- Erectile dysfunction
Diagnosis & Staging of Prostate Cancer
Investigation of urinary bother (also called as LUTS or lower urinary tract symptoms) would be organised which would also include testing for potential existence of prostate cancer. In the clinic after a detailed history examination would include a Digital Rectal Exam (DRE) to delineate the shape, size and texture of the prostate as well as the overlying rectal mucosa. Prostate-Specific Antigen (PSA) is a blood test which is used as a surrogate tumour marker, but it is also elevated in non-cancerous conditions hence a comprehensive overview in assessment is vital.
Treatment for Prostate Cancer
Depending on the stage and other pathological parameters individual patients may be recommended various options which may include active surveillance, robotic radical prostatectomy, radiation therapy, hormone therapy, HIFU. Early detection and appropriate management is vital in long term success.
- Active surveillance
- Robotic radical prostatectomy
- Radiation therapy
- Hormone therapy
- HIFU
Coming in for your prostate cancer appointment
Mercurrey Hospital serves prostate cancer patients from Majiwada, Kapurbawdi, Ghodbunder Road, Manpada, Hiranandani Estate, Brahmand, Owale, Kolshet, and Pokhran Road. Patients from Mira Road and Bhayander seeking the closest Cancer Lead urology on the western Thane axis also attend.
Patient reviews — prostate cancer at Mercurrey Hospital
Amandeep Sodhi
Ghodbunder Road
My corporate health check PSA was 6.8 and nobody explained what to do next. Coming to Mercurrey Hospital resolved the uncertainty. Mr. Godbole calculated my PSA density, arranged mpMRI which showed a PIRADS 4 lesion, and performed targeted biopsy. Gleason 7 (3+4) intermediate-risk cancer confirmed. Radical prostatectomy performed. Six-month post-op PSA is undetectable. The specialist pathway from PSA to diagnosis to treatment was exactly what the situation required.
March 2026
Meena Bhatt
Hiranandani Estate
My husband had an elevated PSA that his GP attributed to prostatitis without any investigation. At Mercurrey Hospital, Mr. Godbole arranged mpMRI which showed no suspicious lesion — confirming that his PSA elevation was from BPH. The PSA is now monitored 6-monthly. That reassurance — properly evidenced by mpMRI rather than assumption — was worth enormously more than the repeated antibiotic courses his GP had prescribed.
February 2026
Naresh Bhandari
Manpada
I researched prostate cancer extensively before my appointment at Mercurrey Hospital. Mr. Godbole's consultation engaged with my research level — discussing Gleason grading, ISUP grade groups, and the evidence behind EAU guideline recommendations for each risk category. The PIRADS 5 lesion on my mpMRI, Gleason 8 on targeted biopsy, and high-risk staging led to a clear recommendation for radical prostatectomy with lymph node dissection. The evidence-based discussion gave me confidence in the treatment plan.
January 2026
Lalitha Krishnamurthy
Brahmand
My father's PSA was 18 — detected at a health camp. The referral to Mercurrey Hospital happened within a week. Mr. Godbole's staging assessment showed locally advanced disease (T3a). Hormone therapy and radiotherapy were coordinated through Mr. Godbole's MDT framework. My father is responding well to treatment. The speed of specialist assessment after the PSA finding was what enabled timely staging and treatment initiation.
March 2026
Pawan Khatri
Kapurbawdi
Living near Kapurbawdi means Mercurrey Hospital is practically my local hospital. My low-risk prostate cancer (Gleason 6, PSA 4.5, Stage T1c) is being managed with active surveillance — a decision I was initially uncomfortable with. Mr. Godbole's detailed explanation of why treatment was not immediately needed for my specific grade and volume of cancer, and what active surveillance involves in practice, gave me the understanding to accept this management plan with confidence.
February 2026
Frequently asked questions
My corporate health screening showed a PSA of 5.2 in Hiranandani Estate — what should I do?
A PSA of 5.2 requires specialist clinical interpretation — not just comparison to a generic reference range. Whether this level is concerning depends on your age (PSA rises with age as a normal finding), your prostate size (estimated by DRE), and whether any prior PSA values are available for comparison. At Mercurrey Hospital, Mr. Godbole provides this full clinical interpretation. Call +91 88280 71522 for an appointment.
What is the PIRADS scoring system for prostate MRI and what does my report mean?
PIRADS (Prostate Imaging-Reporting and Data System) scores MRI lesions from 1 (very low probability of significant cancer) to 5 (very high probability). PIRADS 1 and 2 are reassuring — no biopsy needed in most cases. PIRADS 3 is equivocal — clinical factors determine whether biopsy is warranted. PIRADS 4 and 5 warrant targeted biopsy of the specific lesion. Mr. Godbole's assessment at Mercurrey Hospital interprets your specific PIRADS score in the context of your PSA and DRE findings.
Is transperineal prostate biopsy available through HRG Urology at Mercurrey Hospital, Majiwada?
Transperineal prostate biopsy — performed through the perineal skin under local or general anaesthesia — has a significantly lower infection risk than the traditional transrectal approach (TRUS biopsy) and is increasingly recommended as the standard approach in international guidelines. Mr. Godbole's team arranges transperineal biopsy where clinically indicated for patients assessed through HRG Urology at Mercurrey Hospital.
What is the difference between radical prostatectomy and radiotherapy for prostate cancer?
Both radical prostatectomy (surgical removal of the prostate) and radical radiotherapy (high-dose radiation to the prostate) achieve equivalent cancer control for localised prostate cancer. The differences are in side effect profiles: surgery has higher initial urinary incontinence and erectile dysfunction rates that improve over 12–18 months; radiotherapy has lower initial side effects but higher rates of late bowel and urinary complications. The choice between them depends on tumour characteristics, patient age and fitness, and patient preference. Mr. Godbole presents both options with their specific evidence at the Mercurrey Hospital consultation.
Can prostate cancer spread to bones, and how is this assessed?
Yes. Bone is the most common site of prostate cancer metastasis. Bone metastases cause pain, fracture risk, and are a principal cause of prostate cancer-related mortality in advanced disease. Bone scan or PSMA PET-CT (where available) is used to assess for bone metastases in intermediate and high-risk localised disease and in recurrent or advanced disease. Mr. Godbole's staging pathway at Mercurrey Hospital includes appropriate imaging for bone involvement where indicated by risk stratification.
Risk factors for prostate Cancer:
Older Age A family history of prostate cancer Obesity Genetic Changes Race/ethnicity (black males are at a higher risk of prostate cancer)
Symptoms of Prostate Cancer:
Prostatic symptoms may be similar for both benign and malignant causes and early urological attention and care would be advisable for some or all symptoms as below: Trouble urinating Blood in semen Decreased size and strength of urine stream Discomfort in pelvic area Erectile dysfunction
Diagnosis & Staging of Prostate Cancer
Investigation of urinary bother (also called as LUTS or lower urinary tract symptoms) would be organised which would also include testing for potential existence of prostate cancer. In the clinic after a detailed history examination would include a Digital Rectal Exam (DRE) to delineate the shape, size and texture of the prostate as well as the overlying rectal mucosa. Prostate-Specific Antigen (PSA) is a blood test which is used as a surrogate tumour marker, but it is also elevated in non-cancerous conditions hence a comprehensive overview in assessment is vital.
Treatment for Prostate Cancer
Depending on the stage and other pathological parameters individual patients may be recommended various options which may include active surveillance, robotic radical prostatectomy, radiation therapy, hormone therapy, HIFU. Early detection and appropriate management is vital in long term success. Active surveillance Robotic radical prostatectomy Radiation therapy Hormone therapy HIFU